Olanzapine in Schizophrenia and Affective Disorders

被引：0
|
作者：
Juan Undurraga
Eduard Vieta
Mauricio Tohen
Francesc Colom
机构：
[1] IDIBAPS,Bipolar Disorders Program, Institute of Neuroscience, Hospital Clínic Barcelona
[2] CIBERSAM,Division of Mood and Anxiety Disorders
[3] University of Barcelona,undefined
[4] University of Texas Health Science Center at San Antonio,undefined
来源：
Drug Safety | 2012年 / 35卷
关键词：
Schizophrenia; Bipolar Disorder; Haloperidol; Olanzapine; Drug Exposure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1186
页数：1
相关论文
共 50 条
  • [1] Olanzapine in Schizophrenia and Affective Disorders
    Undurraga, Juan
    Vieta, Eduard
    Tohen, Mauricio
    Colom, Francesc
    [J]. DRUG SAFETY, 2012, 35 (12) : 1185 - 1186
  • [2] Olanzapine in Schizophrenia and Affective Disorders Reply
    Stip, Emmanuel
    Moteshafi, Hoda
    [J]. DRUG SAFETY, 2012, 35 (12) : 1186 - 1186
  • [3] Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders A Meta-Analysis
    Moteshafi, Hoda
    Zhornitsky, Simon
    Brunelle, Sarah
    Stip, Emmanuel
    [J]. DRUG SAFETY, 2012, 35 (10) : 819 - 836
  • [4] Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis
    Baldessarini, Ross J.
    [J]. DRUG SAFETY, 2012, 35 (12) : 1183 - 1183
  • [5] Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis
    Ross J. Baldessarini
    [J]. Drug Safety, 2012, 35 : 1183 - 1183
  • [6] Affective priming in paranoid schizophrenia treated with olanzapine or risperidone
    Kuklinska, M.
    Rataj, K.
    Gorzelanczyk, E. J.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S112 - S113
  • [7] Catatonia, schizophrenia, and affective disorders
    Chalasani, P.
    Healy, D.
    Karthikeya, K.
    Parlapalli, T.
    Morriss, R.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (07): : 897 - 898
  • [8] Genetics of schizophrenia and affective disorders
    Maier, W
    Zobel, A
    Rietschel, M
    [J]. PHARMACOPSYCHIATRY, 2003, 36 : S195 - S202
  • [9] Neuroprotective agents in schizophrenia and affective disorders
    Krebs, Michael
    Leopold, Karolina
    Hinzpeter, Axel
    Schaefer, Martin
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (07) : 837 - 848
  • [10] SCHIZOPHRENIA AFFECTIVE-DISORDERS AND CLOZAPINE
    MEYNARD, JA
    BERNADET, R
    SANCHEZ, MF
    MOREL, P
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1995, 21 : 41 - 47
12345